CD274 and cancer: However, the blockade of the PD-L1/PD-1 pathway may interfere with cancer cell viability independently of the interaction with immune system cells; in fact, it has been reported that in osteosarcoma cells atezolizumab is also able to induce apoptosis, autophagy and activating JNK pathway (Liu et al., 2021).